{name}
{subtitle}
Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors
city
~9 mi. (Cordona, Italy, +28 more cities)
facility
C.H. Regional Reina Sofia - PPDS
drug
atezolizumab, +1 more drug
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~29 mi. (Novara, Italy, +260 more cities)
facility
University of Eastern Piedmont - Maggiore della Carità University Hospital
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~29 mi. (Legnano, Italy, +156 more cities)
facility
Ospedale Civile di Legnano - ASST Ovest Milanese /ID# 222989
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation
city
~29 mi. (Novara, Italy, +50 more cities)
facility
SCDU Ematologia
drug
obinutuzumab, +1 more drug
drug type
chemotherapy, +1 more type
Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma
city
~30 mi. (Via Manzoni, Italy, +31 more cities)
facility
IRCCS istituto Clinico Humanitas U.O. di Oncologia ed Ematologia
condition
Diffuse Large B-Cell Lymphoma, +1 more condition
drug
ibrutinib, +1 more drug
drug type
chemotherapy, +2 more types
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
city
~36 mi. (Ponderano, Italy, +383 more cities)
facility
Ospedale Degli Infermi Di Biella; Reparto Oncologia Medica
biomarker
ER Negative, +2 more biomarkers
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +1 more type
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
city
~50 mi. (Milan, Italy, +147 more cities)
facility
Istituto Europeo di Oncologia ( Site 0536)
condition
Cervical Adenocarcinoma, +2 more conditions
drug
brachytherapy, +3 more drugs
drug type
chemotherapy, +2 more types
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
city
~50 mi. (Milan, Italy, +140 more cities)
facility
ASST Grande Ospedale Metropolitano Niguarda-Oncologia Falck ( Site 0331)
drug
lenvatinib, +2 more drugs
drug type
chemotherapy, +2 more types